S0003733

Dolutegravir 50mg tabs/PAC-30


Dolutegravir 50mg tablets, in a bottle pack of 30 without or without outer carton.
Indicative Price 2.80 USD

General description:
Dolutegravir 50mg tablets, in a bottle pack of 30 without or without outer carton.

Technical specifications:
Each tablet contains dolutegravir sodium equivalent to 50 mg dolutegravir

Therapeutic class:
Dolutegravir is an integrase Inhibitor.

Dosage, Instructions for use:
Please refer to the guideline WHO Model Formulary 2008:
http://apps.who.int/iris/bitstream/handle/10665/44053/9789241547659_eng. pdf?sequence=1
https://www.who.int/publications/i/item/9789241547659
For more details, please see WHO treatment guidelines https://www.who.int/publications/i/item/9789240031593 and WHO Essential Medicines Library https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02 or your regional/national guidelines.


Shelf life:
24 months

Storage conditions:
Do not store above 30°C

Component of a KIT:
This item is a component of S9901023 - IEHK2017, PEP kit (S1400653 - Dolutegravir 50mg tabs/PAC-30 gb)

Alternative products:
S1400653 - Dolutegravir 50mg tabs/PAC-30 gb

Related Products